Incorporating social justice and stigma in cost-effectiveness analysis: drug-resistant tuberculosis treatment
2017 ◽
Vol 21
(11)
◽
pp. 69-74
◽
A. Zwerling
◽
D. Dowdy
◽
A. von Delft
◽
H. Taylor
◽
M. W. Merritt
2018 ◽
Vol 18
(6)
◽
pp. 677-689
◽
Ana-Maria Ionescu
◽
Abela Mpobela Agnarson
◽
Chrispin Kambili
◽
Laurent Metz
◽
Jonathan Kfoury
◽
...
2015 ◽
Vol 95
◽
pp. S212-S216
◽
Zsuzsanna Jakab
◽
Colleen D. Acosta
◽
Hans H. Kluge
◽
Masoud Dara
Brett E. Youngerman
◽
Uma V. Mahajan
◽
Timothy G. Dyster
◽
Shraddha Srinivasan
◽
Casey H. Halpern
◽
...
2018 ◽
Vol 51
(3)
◽
pp. 1800274
◽
William E. Rudgard
◽
Nancy S. das Chagas
◽
Regina Gayoso
◽
Mauricio L. Barreto
◽
Delia Boccia
◽
...
2020 ◽
Vol 79
◽
pp. 163-168
Kingthong Anurat
◽
Chaiyos Khongkhatithum
◽
Oraluck Pattanaprateep
◽
Wichana Chamroonrat
◽
Atthaporn Boongird
◽
...
Denise Evans
◽
Tembeka Sineke
◽
Kathryn Schnippel
◽
Rebecca Berhanu
◽
Caroline Govathson
◽
...
2019 ◽
Vol 9
(1)
◽
pp. S83-S85
◽
G. Kama
◽
G. K. L. Huang
◽
M. Taune
◽
R. Arura
◽
L. Morris
◽
...
2011 ◽
Vol 39
(3)
◽
pp. 626-634
◽
O. Oxlade
◽
D. Falzon
◽
D. Menzies
L. Utaminingsih
◽
D. Hasan
◽
A. Kosasih